Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade Via E-learning - a Multicenter Interrupted Time Series Study (INVERT Study)

NCT02925143 is registered in ClinicalTrials.gov with Herlev Hospital as lead sponsor.

NCT NCT02925143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02925143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade Via E-learning - a Multicenter Interrupted Time Series Study (INVERT Study)
Lead sponsor
Herlev Hospital
Phase
Not applicable
Overall status
Completed
Start date
November 21, 2016
Completion date
June 30, 2017
Enrollment
6,525 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular blockade